Patent details

EP2321651 Title: IDENTIFICATION OF SUBJECTS BEING SUSCEPTIBLE TO ANTI-ANGIOGENESIS THERAPY

  • Data
  • Documents

Basic Information

Publication number:
EP2321651
PCT Application Number:
EP2009059505
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP098000698
PCT Publication Number:
WO2010010153
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IDENTIFICATION OF SUBJECTS BEING SUSCEPTIBLE TO ANTI-ANGIOGENESIS THERAPY
French Title of Invention:
Identification de sujets susceptibles à une thérapie anti-angiogénèse
German Title of Invention:
IDENTIFIKATION VON FÜR EINE ANTI-ANGIOGENESE-THERAPIE GEEIGNETEN PERSONEN
SPC Number:

Dates

Filing date:
23/07/2009
Grant date:
23/08/2017
EP Publication Date:
18/05/2011
PCT Publication Date:
28/01/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/08/2017
EP B1 Publication Date:
23/08/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/07/2018
Expiration date:
23/07/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/08/2017
 
 

Name:
F. Hoffmann-La Roche AG
Address:
Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Inventor

1

Name:
HORSCH, Andrea
Address:
Germany (DE)

2

Name:
HESS, Georg
Address:
Germany (DE)

3

Name:
ZDUNEK, Dietmar
Address:
Germany (DE)

Priority

Priority Number:
08161014
Priority Date:
23/07/2008
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
G01N 33/68;

Publication

European Patent Bulletin

1

Issue number:
201734
Publication date:
23/08/2017
Description:
Grant (B1)

2

Issue number:
201826
Publication date:
27/06/2018
Description:
Opposition procedure started
Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer: